CS1 Targeted CAR-T Cells (MB-104) for the Treatment of Multiple Myeloma Shows Antitumor Activity Sparing Normal T-Cells Despite the Common Expression of CS1

被引:0
|
作者
Gumlaw, Nathan [1 ]
Joseph, Aviva [1 ]
Edinger, James [1 ]
Patel, Ekta [1 ]
机构
[1] Mustang Bio, Res & Dev, Worcester, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
421
引用
收藏
页码:189 / 190
页数:2
相关论文
共 37 条
  • [1] Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Berahovich, Robert
    Sun, Jinying
    Valentine, Michael
    Xu, Shirley
    Harto, Hizkia
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    BIOMEDICINES, 2021, 9 (10)
  • [2] Universal CAR T-Cells Targeting CS1 (UCARTCS1) for the Treatment of Multiple Myeloma
    Gouble, Agnes
    Galetto, Roman
    Mathur, Rohit
    Filipe, Stephanie
    Chion-Sotinel, Isabelle
    Yang, Jing
    He, Jin
    Orlowski, Robert
    Neelapu, Sattva
    Smith, Julianne
    MOLECULAR THERAPY, 2018, 26 (05) : 63 - 63
  • [3] UCARTCS1A: Allogeneic CAR T-Cells Targeting CS1 as Treatment for Multiple Myeloma
    Galetto, Roman
    Mathur, Rohit
    Dusseaux, Mathilde
    Chion-Sotinel, Isabelle
    Yang, Jing
    Le Clerre, Diane
    Filipe, Stephanie
    Neelapu, Sattva
    Smith, Julianne
    Gouble, Agnes
    Depil, Stephan
    MOLECULAR THERAPY, 2019, 27 (04) : 73 - 74
  • [4] ADOPTIVE IMMUNOTHERAPY OF MULTIPLE MYELOMA (MM) WITH ALLOGENIC CAR T-CELLS TARGETING CS1: ENHANCEMENT OF CAR ACTIVITY THROUGH CS1 GENE INACTIVATION IN EFFECTOR CELLS
    Galetto, R.
    Chion-Sotinel, I.
    Francon, P.
    Smith, J.
    HAEMATOLOGICA, 2015, 100 : 286 - 286
  • [5] CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells
    Julie O’Neal
    Julie K. Ritchey
    Matthew L. Cooper
    Jessica Niswonger
    L. Sofía González
    Emily Street
    Michael P. Rettig
    Susan W. Gladney
    Leah Gehrs
    Ramzi Abboud
    Julie L. Prior
    Gabriel J. Haas
    Reyka G. Jayasinghe
    Li Ding
    Armin Ghobadi
    Ravi Vij
    John F. DiPersio
    Leukemia, 2022, 36 : 1625 - 1634
  • [6] CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells
    O'Neal, Julie
    Ritchey, Julie K.
    Cooper, Matthew L.
    Niswonger, Jessica
    Sofia Gonzalez, L.
    Street, Emily
    Rettig, Michael P.
    Gladney, Susan W.
    Gehrs, Leah
    Abboud, Ramzi
    Prior, Julie L.
    Haas, Gabriel J.
    Jayasinghe, Reyka G.
    Ding, Li
    Ghobadi, Armin
    Vij, Ravi
    DiPersio, John F.
    LEUKEMIA, 2022, 36 (06) : 1625 - 1634
  • [7] Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
    Zah, Eugenia
    Nam, Eunwoo
    Bhuvan, Vinya
    Tran, Uyen
    Ji, Brenda Y.
    Gosliner, Stanley B.
    Wang, Xiuli
    Brown, Christine E.
    Chen, Yvonne Y.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [8] Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
    Eugenia Zah
    Eunwoo Nam
    Vinya Bhuvan
    Uyen Tran
    Brenda Y. Ji
    Stanley B. Gosliner
    Xiuli Wang
    Christine E. Brown
    Yvonne Y. Chen
    Nature Communications, 11
  • [9] CS1 Targeted Chimeric Antigen Receptors (CAR) for Treatment of Multiple Myeloma
    O'Neal, Julie
    Ritchey, Julie K.
    Cooper, Matthew
    Niswonger, Jessica
    Kim, Miriam
    Ghobadi, Armin
    DiPersio, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Bypassing the Constraint for Chimeric Antigen Receptor (CAR) Development in T-Cells Expressing the Targeted Antigen: Improvement of Anti-CS1 CAR Activity in Allogenic TCRa/CS1 Double Knockout T-Cells for the Treatment of Multiple Myeloma (MM)
    Galetto, Roman
    Chion-Sotinel, Isabelle
    Gouble, Agnes
    Smith, Julianne
    BLOOD, 2015, 126 (23)